Mochida Submits NDA For Antidepressant Lexapro In Japan
This article was originally published in PharmAsia News
Executive Summary
Mochida Pharmaceutical has submitted a new drug application for Lexapro (escitalopram) with the Ministry of Health, Labor and Welfare